FDA Action Alert: Verrica, Citius and Daiichi Sankyo
After beginning July with a splash in the Alzheimer’s space, the FDA is expected to make three decisions during the next two weeks; two for cancer and one for a viral skin disease.
FDA Action Alert: Verrica, Citius and Daiichi Sankyo Read More »
